Lakewood-Amedex Biotherapeutics CEO presents at H.C. Wainwright Global Investment Conference
LABT•Conference presentation scheduled
- Lakewood-Amedex Biotherapeutics will present virtually at the H.C. Wainwright 28th Annual Global Investment Conference on Sept. 14-16, 2026.
- CEO Kelvin Cooper is scheduled for one-on-one meetings with registered investors and potential partners during the conference.
